These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13488330)

  • 21. [Comparative studies on the method for the purification of immune antitumor sera].
    STEPINA VN
    Vopr Onkol; 1962; 8(2)():12-5. PubMed ID: 13916941
    [No Abstract]   [Full Text] [Related]  

  • 22. [Still on immunology of an experimental tumor of the mouse: attempts at protection by means of immune serums].
    Serafini NA; Ferrari S
    Ann Ist Carlo Forlanini; 1965; 25(3):305-8. PubMed ID: 5863699
    [No Abstract]   [Full Text] [Related]  

  • 23. [Production of anti-cancer sera of narrow specificity].
    NAZARENKO NA
    Vopr Onkol; 1960; 6(3)():14-8. PubMed ID: 14426259
    [No Abstract]   [Full Text] [Related]  

  • 24. [TREATMENT RESEARCH WITH IMMUNE SERUMS IN RATS BEARING EXPERIMENTALLY TRANSPLANTED TUMORS. (EXPERIMENTAL RESEARCH). V].
    TENDELLA E; GELMI G
    Acta Chir Ital; 1963; 19():1167-77. PubMed ID: 14121897
    [No Abstract]   [Full Text] [Related]  

  • 25. [ON OBTAINING SPECIFIC ANTI-CANCER SERUMS].
    SAAKOV AK
    Biull Eksp Biol Med; 1963 Sep; 56():95-8. PubMed ID: 14124795
    [No Abstract]   [Full Text] [Related]  

  • 26. IMMUNITY TO TRANSPLANTABLE TUMORS FOLLOWING VIRAL ONCOLYSIS. I. MECHANISM OF IMMUNITY TO EHRLICH ASCITES TUMOR.
    LINDENMANN J
    J Immunol; 1964 Jun; 92():912-9. PubMed ID: 14218302
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of an immune serum and cytotoxic drugs on a transplantable tumor.
    PRESTON FW; JACKSON EJ; HENEGAR GC; SCHREK R
    Acta Unio Int Contra Cancrum; 1960; 16():718-21. PubMed ID: 14434786
    [No Abstract]   [Full Text] [Related]  

  • 28. [Method of production of immune serum specific to human cancer].
    KOSIAKOV PN; KOROSTELEVA VS; KUZNETSOVA NI
    Biull Eksp Biol Med; 1955 Sep; 40(9):63-5. PubMed ID: 13276474
    [No Abstract]   [Full Text] [Related]  

  • 29. Production of antitumour factors in homologous and heterologous immune systems.
    SEKLA B; HOLECKOVA E
    Acta Unio Int Contra Cancrum; 1962; 18():76-9. PubMed ID: 13910385
    [No Abstract]   [Full Text] [Related]  

  • 30. [ULTRASTRUCTURAL CELL CHANGES IN GUERIN'S CARCINOMA UNDER THE INFLUENCE OF ANTITUMOR SERA].
    UMANSKII IuA; PINCHUK VG; MONASTYRSKAIA BD
    Dokl Akad Nauk SSSR; 1965; 161():221-3. PubMed ID: 14283485
    [No Abstract]   [Full Text] [Related]  

  • 31. [CHANGES INDUCED BY MEANS OF PREVENTIVE TREATMENT, WITH IMMUNE SERUMS BEFORE AND AFTER TRANSPLANTATION OF TUMOR GRAFTS IN RATS. (EXPERIMENTAL RESEARCH). VI].
    GELMI G; TENDELLA E
    Acta Chir Ital; 1963; 19():1179-89. PubMed ID: 14121898
    [No Abstract]   [Full Text] [Related]  

  • 32. [POTENTIATIES OF THE ANTITUMOR ACTIVITY OF SARCOLYSIN BY HETEROLOGOUS IMMUNE SERUMS].
    BONMASSAR E; DIROBERTO F; CELI ML; PRADA A
    Arch Ital Patol Clin Tumori; 1964; 152():291-301. PubMed ID: 14265674
    [No Abstract]   [Full Text] [Related]  

  • 33. THE EFFECTS OF ANTIBODIES ON CELLS. II. CHANGES IN THE ELECTROPHORETIC MOBILITY OF ASCITES TUMOUR CELLS TREATED WITH ANTIBODIES AND COMPLEMENT.
    FORRESTER JA; DUMONDE DC; AMBROSE EJ
    Immunology; 1965 Jan; 8(1):37-48. PubMed ID: 14245310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acquired immunological tolerance as a basis for the production of specific anti-cancer sera].
    MOL'KOV IU N
    Neoplasma; 1959; 6():113-24. PubMed ID: 14423325
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of cytotoxins and leuko-agglutinins in human transplantation sera: implications regarding human tissue typing.
    Stumpf JN; McDonald JC
    Surg Forum; 1968; 19():245-6. PubMed ID: 4887923
    [No Abstract]   [Full Text] [Related]  

  • 36. [ANTIBODIES AGAINST THE SPECIFIC ANTIGEN OF THE TUMOR CELL MEMBRANE].
    BRONDZ BD
    Vopr Onkol; 1964; 10():81-8. PubMed ID: 14149592
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytotoxic effects of antisera against human epithelial cells grown in tissue culture.
    HABEL K; HORNIBROOK JW; GREGG NC
    Ann N Y Acad Sci; 1957 Dec; 69(4):801-3. PubMed ID: 13488331
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of soluble cytotoxins in cell-mediated immunity.
    Walker SM; Lucas ZJ
    Transplant Proc; 1973 Mar; 5(1):137-40. PubMed ID: 4572090
    [No Abstract]   [Full Text] [Related]  

  • 39. CYTOTOXIC AGENTS IN MALIGNANT DISEASE 1.
    WALES R
    Nurs Times; 1965 Jun; 61():790-1. PubMed ID: 14292328
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of antireticular cytotoxic serum in atrophic rhinitis (ozena).
    JACKSON CC
    Laryngoscope; 1946 Jul; 56():342-51. PubMed ID: 20994684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.